PRESCRIPTION NUMBING CREAM FOR DERMATOLOGY
Compounded multi-agent topical anesthetics engineered for dermatologic procedures. Faster onset, deeper penetration, and longer duration than commercial alternatives.
WHY DERMATOLOGISTS CHOOSE COMPOUND ANESTHETICS
Over-the-counter topical anesthetics are limited to a maximum of 4-5% lidocaine. For the procedural demands of a dermatology practice, these concentrations are inadequate. OTC products deliver shallow, short-lived numbness that fails during laser passes, excisions, and deeper tissue work.
Prescription compounded topical anesthetics solve this by combining multiple anesthetic agents at concentrations that far exceed OTC limits. A compounded BLT cream at 20/10/10 delivers three distinct agents through separate pharmacological pathways, producing additive and synergistic anesthesia that a single-agent product cannot match.
Multi-agent formulations also reduce the required concentration of any individual agent, lowering the risk of systemic toxicity while increasing total anesthetic effect at the tissue level. For dermatologists performing back-to-back procedures across large surface areas, this therapeutic index advantage is clinically significant.
Compounded formulations deliver lidocaine at 10-30%, tetracaine at 7-10%, and benzocaine at 20% -- far beyond OTC ceilings.
Combining ester and amide anesthetics blocks sodium channels through independent mechanisms for deeper, more reliable numbness.
Phenylephrine 0.5% localizes the anesthetic at the treatment site, extends duration, and reduces procedural bleeding.
DERMATOLOGY PROCEDURES REQUIRING TOPICAL ANESTHESIA
Prescription numbing cream is indicated across the full spectrum of dermatologic procedures. Each procedure type demands specific anesthetic depth, onset timing, and duration.
LASER RESURFACING
Ablative and non-ablative laser resurfacing generates significant thermal discomfort across broad treatment areas. Compound numbing cream applied under occlusion 30-45 minutes prior to the procedure provides consistent anesthesia across the full facial field. Multi-agent formulations maintain efficacy through multiple laser passes.
MOHS SURGERY
While Mohs micrographic surgery relies primarily on injectable local anesthesia, topical compound anesthetic applied prior to the initial injection significantly reduces needle-insertion pain. For patients requiring multiple stages over several hours, reapplication between stages improves comfort during an already lengthy procedure.
SKIN BIOPSIES
Punch biopsies, shave biopsies, and excisional biopsies all benefit from pre-procedural topical anesthesia. Applying prescription lidocaine cream 20-30 minutes before the biopsy reduces or eliminates the need for injectable lidocaine at the biopsy site, streamlining workflow and reducing patient anxiety.
CRYOTHERAPY
Liquid nitrogen cryotherapy for actinic keratoses, warts, and superficial lesions produces sharp, burning discomfort. Pre-treatment with compounded topical anesthetic reduces pain perception during freeze cycles and minimizes the vasovagal response seen in sensitive patients, particularly when treating multiple lesions in a single session.
CHEMICAL PEELS
Medium-depth and deep chemical peels -- including TCA peels and phenol-croton oil formulations -- cause significant stinging and burning during application. Topical anesthesia applied beforehand reduces patient discomfort without interfering with peel penetration, provided the anesthetic is fully removed before acid application.
IPL PHOTOTHERAPY
Intense pulsed light treatments for vascular lesions, pigmentation, and photorejuvenation produce a snapping, heat-based discomfort with each pulse. Pre-treatment topical anesthesia allows higher fluence settings and more aggressive treatment parameters, improving clinical outcomes while maintaining patient comfort throughout the session.
COMPOUND FORMULATIONS EXPLAINED
Understanding the pharmacology behind each compounded formulation and how agent selection affects clinical performance in dermatologic procedures.
BLT 20/10/10
The most widely prescribed compounded topical anesthetic in dermatology. Benzocaine 20% provides rapid surface-level sodium channel blockade within minutes of application. Lidocaine 10% penetrates deeper tissue layers as an amide anesthetic with a distinct metabolic pathway. Tetracaine 10% extends the duration of numbness with its long half-life. The three agents attack pain signal transmission through complementary mechanisms, producing reliable anesthesia across both superficial and mid-dermal tissue layers. This is the formulation found in MediCaine Pro.
LT 30/7 HIGH-CONCENTRATION
A dual-agent formulation that maximizes lidocaine concentration at 30% paired with tetracaine at 7%. This approach delivers the deepest tissue penetration of any topical formulation, relying on the high lidocaine load to saturate nerve fibers at depth. The trade-off is a slightly longer onset time compared to BLT and a shorter overall duration window. Ideal for procedures requiring maximum depth of anesthesia over a focused area. This is the formulation found in MediCaine Elite.
QUAD-AGENT BLT+ WITH PRILOCAINE
The maximum-potency formulation adds prilocaine 8% as a fourth anesthetic agent to the BLT base. Prilocaine is an amide anesthetic that works synergistically with lidocaine while blocking sodium channels at a different binding site. The result is the most comprehensive topical anesthesia available without injection -- four independent agents creating overlapping numbness across all tissue depths with the longest duration window. Phenylephrine 0.5% is included as a vasoconstrictor to localize the agents and reduce procedural bleeding. This is the formulation found in MediCaine Ultra.
COMPOUNDED VS COMMERCIAL PRODUCTS
How MediCaine compounded formulations compare to EMLA, Pliaglis, and other commercially available topical anesthetics used in dermatology.
Compounded BLT / LT / BLT+
Lidocaine 2.5% / Prilocaine 2.5%
Lidocaine 7% / Tetracaine 7%
WHICH TIER FOR YOUR DERMATOLOGY PRACTICE
Selecting the right compound formulation depends on procedure type, treatment area size, and required duration of anesthesia.
Triple-Agent BLT 20/10/10
The versatile workhorse for general dermatology. Recommended for biopsies, cryotherapy, IPL, non-ablative laser, and routine office procedures. Fast onset and reliable mid-depth anesthesia.
High-Concentration LT 30/7
Maximum lidocaine penetration for focused, deep procedures. Recommended for punch biopsies, excisional biopsies, and pre-injection numbing for Mohs surgery. Best for small treatment areas requiring depth.
Quad-Agent Maximum BLT+
The maximum-potency formulation for the most demanding dermatologic procedures. Recommended for ablative laser resurfacing, deep chemical peels, and extended multi-stage procedures. Longest duration available.
Medical grade numbing cream for aesthetic treatments including fillers, microneedling, laser hair removal, and RF microneedling
Procedure-by-procedure topical anesthetic recommendations with application times, depths, and tier matching
Licensed 503A compounding for BLT cream and quad-agent formulations at concentrations beyond commercial limits
NUMBING CREAM FOR DERMATOLOGY
What numbing cream do dermatologists use for procedures?+
Is compounded lidocaine tetracaine cream better than EMLA?+
How long should numbing cream be applied before a laser procedure?+
Do I need a prescription for compound numbing cream?+
What is the strongest numbing cream for dermatology?+
ORDER FOR YOUR PRACTICE
Compounded fresh per order in the USA. Available in cream or ointment, with airless pump or jar packaging.
Licensed providers can order directly through our configurator or call our pharmacist to discuss formulation recommendations for your procedure mix.